Article
Activity-based urinary biomarkers of response and resistance to checkpoint blockade immunotherapy
2020-12-11
Abstract excerpt
Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, yet most patients do not derive clinical benefit and responders can acquire resistance to therapy. Noninvasive biomarkers are needed to indicate early on-treatment response and resistance mechanisms. Here we developed I mmu N e S ensors for mon I torinG c H eckpoint blockade T herapy (INSIGHT), which comprises a library of mass-barcod...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 97ddf24a-48ae-5f23-92d2-3fb48b61f446
- DOI
- 10.1101/2020.12.10.420265
